Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2305]
News [5292]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment...
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
SABCS 2023: Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
SABCS 2023: Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
SABCS 2023: Blood hormone levels key to identifying which post-menopausal women will benefit most from taking anastrozole to prevent breast cancer 
SABCS 2023: Blood hormone levels key to identifying which post-menopausal women will benefit most from taking...
Fungus-fighting protein could help overcome severe autoimmune disease and cancer
Fungus-fighting protein could help overcome severe autoimmune disease and cancer
Protein implicated in tumour growth found to be heavily associated with pancreatic cancer
Protein implicated in tumour growth found to be heavily associated with pancreatic cancer
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma...
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate...
FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma
FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation